Valuation: DocMorris AG

Market Cap 500M 612M 537M 458M 861M 58.91B 875M 5.93B 2.32B 28.96B 2.3B 2.25B 100B P/E 2026 *
-6.52x
P/E 2027 * -13.1x
Enterprise Value 700M 857M 752M 642M 1.21B 82.5B 1.23B 8.31B 3.25B 40.56B 3.22B 3.15B 140B EV / Sales 2026 *
0.57x
EV / Sales 2027 * 0.53x
Free-Float
66.45%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 61 2022-04-27
Director of Finance/CFO 56 2024-09-30
Chief Tech/Sci/R&D Officer - 2024-10-31
Director TitleAgeSince
Chairman 68 2022-04-27
Director/Board Member 53 2019-05-22
Director/Board Member 56 2020-12-31
Change 5-day change 1-year change 3-year change Capi.($)
0.00%0.00% - - 612M
-1.33%-5.61%-24.10%-29.19% 15.25B
-2.62%-3.75%-29.83%-33.86% 7.07B
+0.63%-0.45%-22.57%-8.61% 5.86B
-1.00%+1.63%-9.10%-29.46% 3.94B
-0.16%+0.22%-30.68%-48.68% 3.16B
-1.55%-4.42%+7.67%-31.67% 3.14B
-3.98%-5.93%-42.91%-18.65% 2.93B
+1.50%+2.72%-16.23%+2.16% 2.57B
+2.45%-0.59%+98.62% - 2.5B
Average -9.47%-1.79%-7.68%-24.74% 5.16B
Weighted average by Cap. -2.13%-2.31%-15.96%-26.25%

Financials

2026 *2027 *
Net sales 1.24B 1.51B 1.33B 1.13B 2.13B 146B 2.17B 14.69B 5.74B 71.69B 5.68B 5.56B 248B 1.39B 1.7B 1.49B 1.27B 2.39B 164B 2.43B 16.49B 6.44B 80.51B 6.38B 6.25B 278B
Net income -81.01M -99.18M -87.11M -74.33M -140M -9.55B -142M -962M -376M -4.7B -372M -364M -16.23B -43.68M -53.47M -46.96M -40.08M -75.3M -5.15B -76.46M -519M -203M -2.53B -201M -196M -8.75B
Net Debt 200M 245M 215M 184M 345M 23.59B 350M 2.38B 928M 11.6B 920M 900M 40.1B 236M 289M 254M 217M 407M 27.82B 413M 2.8B 1.09B 13.68B 1.08B 1.06B 47.29B
Logo DocMorris AG
DocMorris AG, formerly Zur Rose Group AG, is a Switzerland-based company engaged in the drug distribution sector. The Company focuses on the wholesale trade of medicines, as well as operation of a mail-order pharmacy. DocMorris operates at the healthcare, technology and e-commerce, with a primary focus on customer-centric digital healthcare and improving medication efficacy. core business is online pharmacy. In addition to prescription medicines (Rx), assortment features over-the-counter (OTC) and consumer health as well as beauty and personal care (BPC) products. Private labels, including nutritional supplements, painkillers, first-aid products and other OTC medicines. The Company's operates under brands such as PromoFarma, DoctiPharma, Apotal, Medpex and Teleclinic, among others
Employees
-
Trader
Investor
-
Global
-
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
9
Last Close Price
10.22CHF
Average target price
10.22CHF
Spread / Average Target
-0.01%

Quarterly revenue - Rate of surprise